You are here: Industry Insights > chief scientific officer

News List

High Purity New England Appoints Chief Scientific Officer contractpharma
April 30, 2021
High Purity New England, a supplier of equipment, process systems, and custom solutions for the biopharma industry, has appointed a new chief scientific officer, Dr. Michael Quesenberry.
Everest Medicines Appoints Jennifer Yang as Chief Scientific Officer prnasia
April 15, 2021
Everest Medicines announced today the appointment of Dr. Jennifer Yang as chief scientific officer. Dr. Yang has two decades of leadership experience in drug discovery and development at global pharmaceutical companies.
Jubilant Therapeutics Appoints Chief Scientific Officer contractpharma
March 10, 2021
Luca Rastelli brings more than 20 years of oncology drug discovery and development experience.
Jubilant Therapeutics appoints Luca Rastelli as Chief Scientific Officer expresspharma
March 10, 2021
Dr Rastelli will lead all aspects of R&D for Jubilant Therapeutics and serve as a scientific liaison for the company to investors, partners and the medical community.
Crystal Denlinger Named Chief Scientific Officer for National Comprehensive Cancer Network prnasia
January 18, 2021
The National Comprehensive Cancer Network® (NCCN®)--an alliance of leading cancer centers--announced the appointment of Crystal S. Denlinger, MD, FACP, to the newly-created role of Senior Vice President, Chief Scientific Officer.
NeuBase Therapeutics Appoints Chief Scientific Officer contractpharma
December 03, 2020
Dr. Curt Bradshaw brings decades of experience in successfully delivering genetic medicines to clinics.
Ascletis appoints new Chief Scientific Officer biospectrumasia
October 09, 2019
Dr. He was a former Global Head of Computational, Biopharmaceutics and Translational PK/PD at Novartis Pharmaceutical Corporation, New Jersey, USA.
InMed Pharmaceuticals Announces the Appointment of Dr. Sazzad Hossain, PhD, MSc, as a Member of the Scientific Advisory Board and his Retirement as Chief Scientific Officer firstwordpharma
January 13, 2019
Dr. Hossain stated, "InMed's continued success in developing cannabinoids to treat serious diseases is vital to me. Unfortunately, given recent personal health concerns, I wish to modify my role to that of a scientific advisor.
Algenuity appoints new Chief Scientific Officer europeanpharmaceuticalreview
May 22, 2018
Algenuity, a leader in algal biology and industrial biotechnology, is delighted to welcome Dr Alex Pudney to the team as Chief Scientific Officer…